Showing results (541-550 of 1,188) with videos related to
Sort By:
Pageof 119
American Journal of Hematology|May 29, 2015
Characteristics, clinical outcome, and prognostic significance of IDH mutations in AMLCourtney D DiNardo, Farhad Ravandi, Sam Agresta, et al.Clinical Lymphoma, Myeloma & Leukemia|July 14, 2018
A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic SyndromeFevzi Firat Yalniz, Naval Daver, Katayoun Rezvani, et al.Cancer|March 26, 2004
Phase I and pharmacokinetic study of a low-clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemiaFrancis J Giles, Martin S Tallman, Guillermo Garcia-Manero, et al.Cancer|August 27, 2009
Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemiaDeborah A Thomas, Hagop M Kantarjian, Wendy Stock, et al.American Journal of Hematology|February 12, 2022
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemiaJayastu Senapati, Mahran Shoukier, Guillermo Garcia-Manero, et al.IEEE Journal of Biomedical and Health Informatics|July 29, 2024
Validation of an IMU-Based Gait Analysis Method for Assessment of Fall Risk Against Traditional MethodsSara Garcia-de-Villa, Luisa Ruiz Ruiz, Guillermo Garcia-Villamil Neira, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2011
Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of allogeneic stem-cell transplantationYiming Chen, Jorge Cortes, Zeev Estrov, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2005
Phase I study of BMS-214662, a farnesyl transferase inhibitor in patients with acute leukemias and high-risk myelodysplastic syndromesJorge Cortes, Stefan Faderl, Elihu Estey, et al.Seminars in Oncology|February 24, 2005
Cytoprotection in acute myelogenous leukemia (AML) therapyDolores Grosso, Joanne Filicko, Guillermo Garcia-Manero, et al.The Journal of Molecular Diagnostics : JMD|July 11, 2006
Application of self-quenched JH consensus primers for real-time quantitative PCR of IGH gene to minimal residual disease evaluation in multiple myelomaJoaquin Martinez-Lopez, Pilar Martinez-Sanchez, Ramon Garcia-Sanz, et al.Pageof 119